Using advanced, proprietary, exosome isolation technology, Kimera produces the highest-purity MSC exosomes at scale to enable clinical development of novel, exosome-based, therapeutic modalities. By harvesting, isolating and purifying the developmental message contained within exosomes produced by perinatal mesenchymal stem cells, we believe further study will demonstrate that it is possible to stimulate healing processes and tissue regeneration that can benefit patients of any age.
Founded in 2012 by Dr. Duncan Ross, Ph.D., Kimera Labs has been the leader in the field of MSC exosome production and isolation. Unlike biologic tissue laboratories that manufacture exosome products by direct processing of donor tissues such as adult bone marrow or placenta, Kimera Labs produces MSC exosomes from isolated mesenchymal stem cells cultures using chemically defined media, which contains no animal or human serum, following regulations laid out by the FDA.